Ligation of Siglec-8: A selective mechanism for induction of human eosinophil apoptosis

Blood

Volumn 101, Issue 12, 2003, Pages 5014-5020

  Nutku, Esra ^b   Aizawa, Hideyuki ^b   Hudson, Sherry A ^b   Bochner, Bruce S ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3 INHIBITOR; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN ANTIBODY; INTERLEUKIN 5; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN 8; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; EOSINOPHIL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

EID: 0038044928     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-10-3058     Document Type: Article

References (42)

1. Bochner BS, Undem BJ, Lichtenstein LM. Immunological aspects of allergic asthma. Annu Rev Immunol. 1994;12:295-335.
2. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med. 2001;344:350-362.
3. Broide D, Sriramarao P. Eosinophil trafficking to sites of allergic inflammation. Immunol Rev. 2001;179:163-172.
4. Rothenberg ME. Mechanisms of disease: eosinophilia. N Engl J Med. 1998;338:1592-1600.
5. Kikly KK, Bochner BS, Freeman S, et al. Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells and basophils. J Allergy Clin Immunol. 2000;105:1093-1100.
6. Floyd H, Ni J, Cornish AL, Zeng Z, et al. Siglec-8: a novel eosirophil-specific member of the immunoglobulin superfamily. J Biol Chem. 2000;275:861-866.
7. Crocker PR, Varki A. Siglecs, sialic acids and innate immunity. Trends Immunol. 2001;22:337-342.
8. Foussias G, Yousef GM, Diamandis EP. Molecular characterization of a Siglec-8 variant containing cytoplasmic tyrosine-based motifs, and mapping of the Siglec-8 gene. Biochem Biophys Res Commun. 2000;278:775-781.
9. Munday J, Kerr S, Ni J, et al. Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor. Biochem J. 2001;355:489-497.
10. Ulyanova T, Blasioli J, Woodford-Thomas TA, Thomas ML. The sialoadhesin CD33 is a myeloid-specific inhibitory receptor. Eur J Immunol. 1999;29:3440-3449.
11. Vitale C, Romagnani C, Puccetti A, et al. Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: engagement of CD33 induces apoptosis of leukemic cells. Proc Natl Acad Sci U S A. 2001;98:5764-5769.
12. Mingari MC, Vitale C, Romagnani C, Falco M, Moretta L p75/AIRM-1 and CD33, two sialo-adhesin receptors that regulate the proliferation or the survival of normal and leukemic myeloid cells. Immunol Rev. 2001;81:260-268.
13. Matsumoto K, Schleimer RP, Saito H, Iikura Y, Bochner BS. Induction of apoptosis in human eosinophils by anti-fas antibody treatment in vitro. Blood. 1995;86:1437-1443.
14. Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson DW, Cohen GM. BenzyloxycarbonylVal-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J. 1996;315:21-24.
15. Walsh GM, Dewson G, Wardlaw AJ, Levi-Schaffer F, Moqbel R. A comparative study of different methods for the assessment of apoptosis and necrosis in human eosinophils. J Immunol Methods. 1998;217:153-163.
16. Toledano BJ, Bastien Y, Noya F, Baruchel S, Mazer B. Platelet-activating factor abrogates apoptosis induced by cross-linking of the surface IgM receptor in a human B lymphoblastoid cell line. J Immunol. 1997;158:3705-3715.
17. Zhang G, Gurtu V, Kain SR, Yan G. Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques. 1997;23:525-531.
18. Aizawa H, Plitt J, Bochner BS. Human eosinophils express two siglec-8 splice variants [letter]. J Allergy Clin Immunol. 2002;109:176.
19. Slee EA, Adrain C, Martin SJ. Executioner caspase-3, -6, and -7 perform distinct, nonredundant roles during the demolition phase of apoptosis. J Biol Chem. 2001;276:7320-7326.
20. Kim J, Schimming A, Kita H. Ligation of Fcγ RII (CD32) pivotally regulates survival of human eosinophils. J Immunol. 1999;162:4253-4259.
21. Kay AB. Allergy and allergic diseases, part 1. N Engl J Med. 2001;344:30-37.
22. Kay AB. Allergy and allergic diseases, part 2. N Engl J Med. 2001;344:109-113.
23. Whitney G, Wang S, Chang H, et al. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33. Eur J Biochem. 2001;268:6083-6096.
24. Burshtyn DN, Yang W, Yi T, Long EO. A novel phosphotyrosine motif with a critical amino acid at position-2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1. J Biol Chem. 1997;272:13066-13072.
25. Coffey AJ, Brooksbank RA, Brandau O, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet. 1998;20:129-135.
26. Sayos J, Wu C. Morra M, et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 1998;395:462-469.
27. Aizawa H, Plitt J, Piantadosi S, Bochner BS. Human eosinophils, basophils, and HMC-1 cells express both short and long splice variants of siglec-8. J Allergy Clin Immunol [abstract]. 2002;109:S225.
28. Kato I, Takai T, Kudo A. The pre-B cell receptor signaling for apoptosis is negatively regulated by FcγRIIB. J Immunol. 2002;168:629-634.
29. Berg KL, Carlberg K, Rohrschneider LR, Siminovitch KA, Stanley ER. The major SHP-1-binding, tyrosine-phosphorylated protein in macrophages is a member of the KFR/LIR family and an SHP-1 substrate. Oncogene. 1998;17:2535-2541.
30. Kuroiwa A, Yamashita Y, Inui M, et al. Association of tyrosine phosphatases SHP-1 and SHP-2, inositol 5-phosphatase SHIP with gp49B1, and chromosomal assignment of the gene. J Biol Chem. 1998;273:1070-1074.
31. Cremesti A, Paris F, Grassme H, et al. Ceramide enables fas to cap and kill. J Biol Chem. 2001;276:23954-23961.
32. Zangrilli J, Robertson N, Shetty A, et al. Effect of IL-5, glucocorticoid, and Fas ligation on Bcl-2 homologue expression and caspase activation in circulating human eosinophils. Clin Exp Immunol. 2000;120:12-21.
33. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci U S A. 1996;93:2239-2244.
34. Blatt NB, Glick GD. Signaling pathways and effector mechanisms pre-programmed cell death. Bioorg Med Chem. 2001;9:1371-1384.
35. Dibbert B, Daigle I, Braun D, et al. Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5. Blood. 1998;92:778-783.
36. Wallen N, Kita H, Weiler D, Gleich GJ. Glucocorticoids inhibit cytokine-mediated eosinophil surviral. J Immunol. 1991;147:3490-3495.
37. Walsh GM, Williamson ML, Symon FA, Willars GB, Wardlaw AJ. Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor. Blood. 1996;87:2815-2821.
38. Crocker PR, Clark EA, Filbin M, et al. Siglecs: a family of sialic-acid binding lectins. Glycobiology. 1998;8(2):v.
39. Butterworth AE, Vadas MA, Wassom DL, et al. Interactions between human eosinophils and schistosomula of Schistosoma mansoni, II: the mechanism of irreversible eosinophil adherence. J Exp Med. 1979;150:1456-1471.
40. Ober C, Cox NJ, Abney M, et al. Genome-wide search for asthma susceptibility loci in a founder population. Hum Mol Genet. 1998;7:1393-1398.
41. Dizier MH, Besse-Schmittter C, Guilloud-Bataille M, et al. Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med. 2000;162:1812-1818.
42. Venanzi S, Malerba G, Galavotti R, et al. Linkage to atopy on chromosome 19 in north-eastern Italian families with allergic asthma. Clin Exp Allergy. 2001;31:1220-1224.